<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00797264</url>
  </required_header>
  <id_info>
    <org_study_id>P060402</org_study_id>
    <nct_id>NCT00797264</nct_id>
  </id_info>
  <brief_title>Ketamine Associated With Morphine PCA After Total Hip Arthroplasty</brief_title>
  <acronym>KETAMINE</acronym>
  <official_title>Impact of the Route of Administration of Ketamine Associated With Morphine PCA on Analgesia After Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ketamine (an analgesic drug often associated with morphine in the treatment of Opioid Induced
      Hyperalgesia) is often mixed in Morphine PCA syringe. We make the hypothesis that ketamine
      administrated separately via a continuous infusion, could induced a better analgesic effect.

      We will perform a randomised double blind study to determine the best infusion mode of
      intravenous ketamine, associated with morphine in PCA syringe or alone in continuous
      infusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Double blind study to determine the best infusion mode of intravenous ketamine, associated
      with morphine in PCA syringe or alone in continuous infusion
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption in PACU and in hospitalisation room</measure>
    <time_frame>at 24 and 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Visual Analogic Score of pain</measure>
    <time_frame>in Recovery Room, at 24 and 48 hours, in the ward</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Measure of mechanical hyperalgesia by Von Frey filament device</measure>
    <time_frame>24 and 48 hours in the ward</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative measure Ketamine and Nor-Ketamine blood levels</measure>
    <time_frame>at 24 and 48 hours in the ward</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine pre and per operative, and morphine postoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NaCl pre and per operative, and morphine postoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine and morphine postoperative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine-Morphine</intervention_name>
    <description>Ketamine bolus preoperative and syringe pump peroperative, and morphine postoperative (PCA)</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Ketamine pre and per operative, and morphine postoperative</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Bolus preoperative of NaCl and syringe pump peroperative of NaCl, and morphine postoperative (PCA)</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Postoperative PCA of Ketamine and morphine</intervention_name>
    <description>Bolus preoperative of NaCl and syringe pump peroperative of Ketamine, and morphine postoperative (PCA)</description>
    <arm_group_label>C</arm_group_label>
    <other_name>Ketamine Morphine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  total hip arthroplasty

        Exclusion Criteria:

          -  pre operative opioid administration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe SITBON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris Hôpital Bicêtre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service d'anesthesie-reanimation - Hôpital Bicêtre</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2008</study_first_submitted>
  <study_first_submitted_qc>November 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2008</study_first_posted>
  <last_update_submitted>April 10, 2013</last_update_submitted>
  <last_update_submitted_qc>April 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ketamine</keyword>
  <keyword>Morphine</keyword>
  <keyword>PCA</keyword>
  <keyword>Hyperalgesia</keyword>
  <keyword>Nor-ketamine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

